CURRENT MANAGEMENT OF THE WOLFF-PARKINSON-WHITE SYNDROME

Citation
Tg. Bartlett et Pl. Friedman, CURRENT MANAGEMENT OF THE WOLFF-PARKINSON-WHITE SYNDROME, Journal of cardiac surgery, 8(4), 1993, pp. 503-515
Citations number
NO
Categorie Soggetti
Cardiac & Cardiovascular System",Surgery
Journal title
ISSN journal
08860440
Volume
8
Issue
4
Year of publication
1993
Pages
503 - 515
Database
ISI
SICI code
0886-0440(1993)8:4<503:CMOTWS>2.0.ZU;2-G
Abstract
In this review, we discuss the pathophysiology of the Wolff-Parkinson- White (WPW) syndrome and describe medical, surgical, and catheter base d principles. WPW syndrome results from the congenital presence of imp ulse-conducting fascicles, known as accessory pathways (APs) or bypass tracts, which connect atria and ventricles across the annulus fibrosi s and are capable of preexciting portions of the ventricular myocardiu m. Once triggered, atrioventricular reciprocating tachycardias (AVRTs) generally result from depolarization wavefronts moving anterograde th rough the AV node to the ventricles and returning retrograde to the at ria along the AP. Rapid AVRT decreases ventricular filling time and ca rdiac output, resulting in symptoms. Medications that prolong AP refra ctory periods (flecainide, propafenone, and amiodarone) prevent rapid AP anterograde conduction (from atria to ventricles) in atrial tachyca rdias such as atrial fibrillation or flutter. In emergencies, adenosin e can be used to terminate the AVRT of WPW syndrome. Otherwise, Class IA or IC antiarrhythmic agents are used to slow AP conduction either w ith or without AV nodal blocking agents. Open chest surgical ablation of a bypass tract in a symptomatic patient was first reported in 1968. The original endocardial surgical techniques for localizing and divid ing APs were refined and an alternative epicardial approach has been d eveloped. Reported mortality rates in experienced hands were 0% to 1.5 % in large series for patients without additional cardiac abnormalitie s. Catheter delivered radiofrequency (RF) energy is now applied intrav ascularly to ablate APs. Since the first large series of patients unde rgoing RF ablation was reported in 1989, the procedure had proved safe , cost effective, and well tolerated. RF ablation has become the initi al nonpharmacological treatment of choice for WPW syndrome; surgical a blation has become relegated to those cases where symptoms are intoler able and RF ablation is not feasible.